SELECTED PUBLICATIONS
RECENT ABSTRACTS:
Sundsmo, J.S., Chow, H. and M. Sagermann. 2012. Keyhole Limpet Hemocyanin (KLH) N-Glycans Share Similar Structural Features with Saccharides of Schistosoma, Trypanosoma, Leishmania, Cryptococcus, Aspergillis, Candida, E. coli, Salmonella, Clostridium and Hepatitis C virus (HCV). ICCAC, San Francisco, September 9, 2012. Poster
Chow, H., Sagermann, M. and J. S. Sundsmo. 2012. Keyhole Limpet Hemocyanin (KLH): A Unique Unlikely Pharmaceutical Product. Immunotherapeutics and Vaccine Summit, Cambridge, MA. Aug. 13-16, 2012. Poster
Lebec, H., Hock, M.B., Sundsmo, J., Mytych, D., Chow, H., Carlock, L., Joubert, M.K., Haynes, J. and J. Bussiere. T-cell Dependent Antibody Responses in the Rat: Forms and Sources of Keyhole Limpet Hemocyanin Matter. Society of Toxicology. San Antonio, TX. March 10-14, 2013.
REVIEWS:
Monteiro, M.A., Ma, Z., Bertolo, L., Jiao, Y., Arroyo, L., Mallozzi, M., Vedantam, G., Sagermann, M., Sundsmo, J. and H. Chow. 2013. Polysaccharide-based Clostridium difficile vaccines. Expert Reviews in Vaccine Science, in press, January 2013 issue.
Sundsmo, J.S. 1987. The Use of "Magic Bullets for the Treatment of Cancer: Monoclonal Antibody Immunotoxins. Triton Corp. Research and Development Notes. January, 1987.
Sundsmo, J.S. 1982. The Leukocyte Complement System. Fed. Proc. 41: 80-84.
Sundsmo, J.S. and D.S. Fair. 1983. Relationships among the complement,kinin, coagulation, and fibrinolytic systems. Springer Sem. Immunopathol. 6:  231-258.
Sundsmo, J.S. and D.S. Fair. 1983. Relationships among the complement, kinin, coagulation, and fibrinolytic systems. Springer Semin Immunopathol. 6(2-3):231-58.
ORIGINAL ARTICLES:
Jiang C, Wan X, Jankovic J, Christian ST, Pristupa ZB, Niznik HB, Sundsmo JS, Le W. 2004. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clin Neuropharmacol. Mar-Apr;27(2):63-73.
Ksander GA, Sawamura SJ, Ogawa Y, Sundsmo J, McPherson JM. 1990. The effect of platelet releasate on wound healing in animal models. J Am Acad Dermatol. May; 22(5 Pt 1):781-91. US4,760,131
DeLustro, F.S., T. Smith, J.S. Sundsmo, G. Salem, S. Kincaid, and L. Ellingsworth. 1987. Reaction to Injectable Collagen Results in Animal Models and Clinical Use. Plastic and Reconstructive Surgery 79: 581-592.
Sundsmo, J.S., R.A. Papin, L. Wood, S. Hirani, N. Waldeck, B. Buckingham, A. Kershnar, M. Ascher, and M.A. Charles. 1985. Complement activation in type 1 human diabetes. Clin. Immunol. Immunopathol. 35: 211-225. [First demonstration: Complement activation in diabetes.]
Charles M, Suzuki M, Sundsmo J, Waldeck N, Negishi K, Slater L, Ong K, Buckingham B, Kershnar A. 1984. Immunological events in new onset diabetes.  Biomed Biochim Acta. 43(5):615-9
Hirani S, Fair DS, Papin RA, Sundsmo JS. 1985. Leukocyte complement: interleukin-like properties of factor Bb. Cell Immunol. 1985 May;92(2):235-46.
Sundsmo JS, Chin JR, Papin RA, Fair DS, Werb Z. Factor B, the complement alternative pathway serine proteinase, is a major constitutive protein synthesized and secreted by resident and elicited mouse macrophages. J Exp Med. 1985 Feb 1;161(2):306-22.
Sundsmo, J.S. 1983.Leukocyte complement: a possible role for C5 in lymphocyte stimulation. J Immunol. Aug;131(2):886-91
Sundsmo JS, Gotze O. 1983. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7 Cell Immunol. Apr 1;77(1):176-86.
Sundsmo, J.S. and L.M. Wood. 1981. Activated Factor B (Bb) of the human complement alternative pathway cleaves and activates plasminogen. J. Immunol. 127: 877-880.
Sundsmo, J.S. and O. Gotze. 1980. Human monocyte spreading induced by Factor B of the alternative pathway of complement activation. Cell. Immunol. 52:1-17.
Sundsmo, J.S. and H.J. Muller-Eberhard. 1979. Neoantigen of the complement membrane attack complex on cytotoxic human peripheral blood lymphocytes. J. Immunol. 122: 2371-2378.
Isenman DE, Sundsmo JS, Cooper NR. 1980. The effects of mild reduction on the structure and function of C3. J Immunol. 1980 Oct;125(4):1798-805.
Curd, J.G., Sundsmo, J.S., Kolb, W.P., Bluestein, H.G., and H.J. Muller-Eberhard. 1978. Neoantigens of the membrane attack complex of human complement on peripheral blood leukocytes from patients with systemic lupus erythematosus. Arth. Rheum. 21: 177-188. [First demonstration: Complement activation on neutrophils in SLE.]
Sundsmo, J.S. and S-I. Hakomori. 1976. Lacto-n-neotetraosylceramide ("paragloboside") a possible tumor-associated surface antigen of hamster Nilpy tumor. Biochem. Biophys. Res. Comm. 68: 799-806. [First demonstration: Glycolipid tumor antigens.]